Agenda
Plenary Sessions
The Digital Lab
The Connected Lab
The Innovation Lab
Clear filters
Download Full Agenda
08:50
Keynote Address: Welcome and Opening Remarks from Session Chair
Plenary Sessions
08:50 EST
Greg Moody, VP Research and Development IT , Biogen
09:00
Keynote Address: Powering Drug Discovery & Development through Data Science
Plenary Sessions
09:00 EST
Mark Borowsky, CIO, Novartis Institute for Biomedical Research

Mark Borowsky, CIO, Novartis Institutes for Biomedical Research

Keynote Address: Exploring Novae Terrae: The Benefits of AI/ML in Pharmaceuticals
Plenary Sessions
09:00 EST
Mark Fischer-Colbrie, CEO, Strateos
  • See how integrated AI and automation systems are up to the task of digitally transforming drug discovery like it has done across other sectors like e-commerce, food packaging, civil engineering
  • Learn about AI-driven solutions for the lab that can help you make efficient decisions in early-phase drug discovery to identify leads
10:00
Keynote: Digital Transformation & Drug Discovery
Plenary Sessions
10:00 EST
Peter Grandsard, Executive Director , Center for Research Acceleration by Digital Innovation (CRADI) Amgen, Inc.
Removing the Moats
  • The vision and mission of the Center for Research Acceleration through Digital Innovation (CRADI)
  • A case study (either generative design or predictive modeling of developability attributes)
  • Change management: upskilling and mindset change to remove the moats
Keynote Address: A Fully Integrated Lab – The Key to Accelerating R&D
Plenary Sessions
10:00 EST
Nathan Clark, CEO & Co-founder, Ganymede
  • Reimagining how biotechs approach data architecture
  • Democratizing analysis to make R&D more intelligent
  • Leveraging automation beyond robotics
11:00
Coffee Break and Exhibition
Plenary Sessions
11:00 EST
12:00
Applying Data, and Technology in the Development of Novel Therapeutics
The Digital Lab
12:00 - 13:00 EST
Susie Stephens, Corporate VP, Data Management & Informatics, Novo Nordisk
Applying Principles of the 4th Industrial Revolution to Accelerate Novel Therapeutic Development
The Digital Lab
12:00 EST
Vasu Rangadass, President & CEO, L7 Informatics
  • Digitalize Data and Meta Data
  • Digitalization of “Work” “Flow”
  • Integrate & Streamline Operations from Research to Development to Manufacturing; and Real-world Data Collection

 

Reducing the drug discovery life cycle with digital tools
The Connected Lab
12:00 - 13:00 EST
Christos Nicolau, Director, Digital Chemistry, Recursion
Extending a Composable IT Architecture into the Laboratory
The Connected Lab
12:00 - 13:00 EST
Geoff Gerhardt, Chief Technology Officer and Co-founder , Scitara
Building the Lab of the Future at Sanofi
The Innovation Lab
12:00 EST
Niv Paterson, AVP, Hub Management Office NA R&D, Sanofi
The AstraZeneca Kendall Square Build
The Innovation Lab
12:00 EST
Robert Albert, Innovation Consultant, AstraZeneca
13:00
Lunch & Exhibition
Plenary Sessions
13:00 EST
14:00
The Lab of the Future in the Manufacturing (QC Release) Domain
The Digital Lab
14:00 EST
John Kelleher, Senior Director, Digital Quality, Pfizer
The True End-to-End Digitalization: Expanding the Term “Digital” Beyond the Simplicity of How Data is Captured
The Digital Lab
14:00 EST
Adam Ryba, Director, Laboratory Informatics Delivery Services, Astrix
Applying Innovative Platform Solutions to Support Scientists
The Connected Lab
14:00 EST
Mohit Agnihotri, Sr Director, Development Sciences Data & Digital Strategy, AbbVie
Empower Scientists’ Decisions and Data Science Projects: Analytical Data Marshalling, Management & Accessibility
The Connected Lab
14:00 EST
Richard Lee, Director, Core Technology Innovation and Informatics Strategy, ACD/Labs
  • Challenges with managing analytical data—heterogeneous data formats and sources; variety of infrastructure
  • Choosing the right vendor for your needs—think complimentary technologies and integrated systems
  • Mapping the appropriate technology foundation for analytical data marshalling
  • Self-assembly and management of automated workflows and cloud-enabled solutions
  • Ensuring data is human and machine usable
Novel Target Discovery and Molecular Design using AI
The Innovation Lab
14:00 EST
Alex Zhavoronkov, CEO, Insilico Medicine

 

 

 

Lab software isn’t enough: a primer on digital experiment software, and why you need it in your lab
The Innovation Lab
14:00 EST
Mathieu Ayel, Chief Product Officer, Synthace
Use Cases View of Artificial Intelligence and Natural Language Processing Solutions in Life Sciences
The Innovation Lab
14:00 EST
Bikalpa Neupane, Director, Advanced Technologies & Experimentation, Takeda

An overview of several use-cases in ‘AI-ML-NLP’ solutions, and how to set up rapid POCs and experimentation for quick wins. Use cases range from applying robotic process automation and classification techniques in self-serve IT infrastructure, intelligent document processing, general natural language generation dashboard, natural language processing techniques in clinical and non-clinical settings, evaluating several models in summarization and extraction spaces, building conversational AI framework and chatbots, testing and trying vendor solutions (AWS, Azure, Watson, Startups etc.). and many more. Please attend if you can, or contact the speaker through his LinkedIn or twitter profile for any questions.

14:50
Accelerating New Medicines by Harnessing the Power of Development Laboratory Data
The Digital Lab
14:50 EST
Leah O’Brien, Senior Product Director, Development Lab Systems, GSK
Integrating Research and Clinical Care: City of Hope’s POSEIDON Turns Real-world Data Into Evidence and Action
The Digital Lab
14:50 EST
Samir Courdy, Sr. Vice President & Chief Informatics Officer, City of Hope Cancer Centre
Kristy Cloyd-Warwick, Vice President, xVantage Success & Care, DNAnexus
Lab Automation Case Study
The Connected Lab
14:50 EST
Priya Vijayakumar Session
The Connected Lab
14:50 EST
Priya Vijayakumar, CEO, WattIQ
Leveraging Flexible Work and Lab Space in a Rich Ecosystem
The Innovation Lab
14:50 EST
Romy Benninga, Medical Affairs and Business Strategy Consultant, Oxfo Corporation
Michelle Ottey, Managing Director, CIC Labs
Mark Federici, Global Director, Business Development for Bio-innovations​, Bioscience Division, Thermo Fisher Scientific
15:40
Afternoon Tea
Plenary Sessions
15:40 EST
16:10
Build vs. Buy: the RoI of Software Purchasing
The Digital Lab
16:10 EST
Jennifer Heymont, Associate Director, Scientific Informatics, Eisai
The Final Frontier: Digitalizing In Vivo Operations for an Open Research Ecosystem
The Digital Lab
16:10 EST
Charles Donnelly, CEO, RockStep Solutions
Novel Technologies Aiding Translational Bioinformatics and Discovery Research
The Digital Lab
16:10 EST
Shameer Khader, Executive Director, Sanofi
Navigating digital & IoT transformation initiatives for lab facilities and the importance of planning for a digital future
The Connected Lab
16:10 EST
Steve Corbesero Jr., Director of Product, MachineQ
Pam Walker, Corporate Vice President, Global Head of Operations, Safety Assessment, Charles River Labs
Driving Innovation through The Lab of the Future – Perspectives from Small Biotech
The Innovation Lab
16:10 EST
Kareem Barghouti, CEO & Founder, Pragmabio
Jeff Carter, CEO & Founder, Scaffold Therapeutics
17:10
Agile Fit for Purpose Infrastructure
The Digital Lab
17:10 EST
Mimika Koletsou, Director, Informatics, Kinnate Biopharma
The key elements of software selection and the implementation process
The Digital Lab
17:10
Anna Carr, Senior Manager, LIMS, SomaLogic, Inc
Doug Lavelle, Founder & Management Consultant, IT Management Specialists
The diverse lab protocols challenge – How do we enable a fully connected and digitalized lab?
The Connected Lab
17:10
Bagavathi Rajan, Vice President – Digital Lab Solutions, Zifo

Typical informatics systems and instrument analysis data don’t provide the full context for your protocols and methods. With recent focus on digitalization to enable productivity/ quality improvements and decision making, it is critical to get the complete context for these results. A fully connected lab is essential to enable this but every lab faces challenges in achieving this with plethora of protocols and instruments, instrument software and applications in place. In this talk, we will discuss the typical challenges faced and an approach to overcome these challenges through our accelerator solution.

Enabling And Supporting Scientific Informatics For Translational Research Collaborations
The Connected Lab
17:10 EST
Jay Bergeron, Sr Director, R&D Data Solutions & Engineering, Pfizer
Making it Easy to Track Samples in Flight (with their Data)
The Innovation Lab
17:10 EST
Erik Bierwagen, Director, Lab Science Informatics, Genentech
Solving this Problem in the In-Vivo and Pathology Space
The Innovation Lab
17:10 EST
Magdalena Osińska, Translational Research Informatics team leader, Genentech
Sample Registration and Tracking in Large Molecule Drug Discovery
The Innovation Lab
17:10 EST
Samantha James, Principal Informatics System Analyst , Genentech
How we’re generalizing these solutions to work across domains and labs
The Innovation Lab
17:10 EST
Sally Madden, Bioinformatics Software Engineer, Genentech
18:00
Drinks Reception
Plenary Sessions
18:00 EST
08:50
Opening Address
Plenary Sessions
08:50
09:00
Keynote Address: Developing and Integrating Diverse Technologies to Enable and Expedite Drug Discovery & Development
Plenary Sessions
09:00
Philip Hajduk, Vice Pre​sident, R​&D Information Research, AbbVie
Keynote Address: Into the Clinic: Transforming the Drug Discovery Process with Digital Chemistry
Plenary Sessions
09:00 EST
Duncan Hamish Wright, Vice President, Translational Science, Schrödinger Therapeutics Group
Erin Davis, Senior Vice President of Enterprise Informatics, Schrödinger
10:00
Keynote Address: Delivering the Lab of the Future through digital transformation
Plenary Sessions
10:00 EST
Diane Wuest, Senior VP, Digital R&D, Sanofi
Keynote Address: Creating a Scientific Platform to Support Preclinical Drug Discovery  
Plenary Sessions
10:00 EST
John Tallarico, Head, Chemical Biology and Therapeutics, Novartis Institute for Biomedical Research
11:00
Coffee & Exhibition
Plenary Sessions
11:00 EST
11:50
Connecting the R&D Lab to Enable a Future AI Strategy
The Digital Lab
11:50 EST
Kristen Ferrara, Global Head of Scientific Informatics; R&D / Vaccines IT and Digital, Takeda
Digital Twins to Unblock Drug Discovery and Novel Target Validation
The Digital Lab
11:50 EST
Richard Harrison, Vice President of Biomedicine, Aitia
  • New modalities & emerging drug targets in oncology, immunotherapy, and neuro
  • Alzheimer Disease use case

 

The Pathways to the Lab of the Future
The Connected Lab
11:50 EST
Mark Burfoot, VP Senior Partner, Head of Research Procurement, Novartis
Sourcing Chemicals in the Lab of the Future
The Connected Lab
11:50 EST
Joseph Pease, Senior Director, Genentech
Integrated Sample Management –  a case study around a sustainable end-to-end solution
The Connected Lab
11:50
Adam Brower, Services Innovation Manager, Avantor
Advancing biologics development through Data Science and Mixed Reality
The Innovation Lab
11:50 EST
Pamela Sepulveda, Director, Digital Strategy, Pfizer
Varsha Daswani, Data Science Business Lead, Pfizer
Heather Farrell, Senior Manager, Knowledge Management Business Lead, Pfizer
Achieving operational excellence in your lab with the right digital tools
The Innovation Lab
11:50 EST
Tobias Wingbermühle, CCO & Co-founder, Clustermarket Ltd

We are entering a digital transformation, where paperless processes and modern cloud solutions are now becoming the norm. The digital era that we now live in is rapidly changing the way we operate in laboratory settings by optimizing equipment usage, improving workflows, reducing waste, and delivering cost savings and faster turnaround times. A real case will help to understand the benefits of a digitally optimized lab operation set up and the different tools that are used to achieve these goals, with a focus on equipment management and scheduling.

12:50
Lunch & Exhibition
Plenary Sessions
12:50 EST
13:40
Leveraging XR Devices, Virtual Lab Assitants and other Leading Edge Technologies to Benefit Biotech Research
The Digital Lab
13:40 EST
Patrick LeBlanc, Director Business Relationship Management, Regeneron
Kristian Kolakowski, Principal Business Analyst, Regeneron
Wasim Sadar, Sr. Project Manager in Research and Development IT for Oncology, Regeneron
Demonstrating Unmatched Potential for Drug Innovation Through AI/ML
The Digital Lab
13:40 EST
Roy Tal, Cofounder and Principal Scientist, Ro5
Marc Siladi, Vice President of Science and Technology , Strateos
LIMS of the Future
The Connected Lab
13:40 EST
Cindy Novak, Associate Director of R&D IS, Avidity Biosciences
Empowering Scientists with an Enterprise Laboratory Platform
The Connected Lab
13:40 EST
Anahita Laskowski, Head of Sales, AgiLab
Implementing a CMC wide ELN strategy
The Connected Lab
13:40 EST
Douglas Scheesley, Scientific Leader, GSK
Lowering Barriers to Innovation in Life Science R&D
The Innovation Lab
13:40 EST
Hall Gregg, Former VP, Business Technology R&D, Pfizer
Reimagining the Lab of the Future via a Public-Private Consortium
The Innovation Lab
13:40 EST
John Baldoni, Chairman, ATOM Consortium
14:40
Taking a Data Centric Approach to Large Molecule Research
The Digital Lab
14:40 EST
Yves Fomekong Nanfack, Director, Head of Operations Digital Biologics Platform, Sanofi
Research Technologies and Unmet Needs
The Connected Lab
14:40 - EST
Todd Maloney, Executive Director, Eli Lilly & Co
James Vergis, Secretariat, Enabling Technologies Consortium
Matthew Bahr, Scientific Team Leader, GSK
Daniel Patience, Head of Chemical Engineering, Small Molecules, Biogen

Todd Maloney, Executive Director, Eli Lilly & Co

James Vergis, Secretariat, Enabling Technologies Consortium 

Matthew Bahr, Scientific Team Leader, GSK

Daniel Patience Head of Chemical Engineering, Small MoleculesBiogen

 

Reimagining AI in Biopharma
The Connected Lab
14:40 EST
Tom Chittenden, CSO & President of R&D, Bio-AI Health
Abhishek Jha, Co-Founder & CEO, Elucidata
17:00
Close Conference
Plenary Sessions
17:00